Content validation of the SF-36v2® Health Survey Acute for use in hypoparathyroidism.

"Declarations Conflict of interestM. Brod is a consultant to the pharmaceutical industry, including Ascendis Pharma. L.T. Waldman was a consultant to the pharmaceutical industry and an employee of The Brod Group when the study was conducted. A. Smith and A.D. Shu are employees of Ascendis Pharma, Inc. Ethical approvalThis study was performed in line with the principles of the Declaration of Helsinki. Ethics approval was granted by WCG IRB, Washington, US [AS-HP-SF-36 CD 2021; IRB Number: 20213924]. Consent to participateInformed consent was obtained from all individual participants included in the study. Consent to publishNot applicable. Conflict of interest M. Brod is a consultant to the pharmaceutical industry, including Ascendis Pharma. L.T. Waldman was a consultant to the pharmaceutical industry and an employee of The Brod Group when the study was conducted. A. Smith and A.D. Shu are employees of Ascendis Pharma, Inc."

"Funding This study was funded by Ascendis Pharma, Inc."